GI & Endoscopy

A study presented at the 2017 European Congress of Clinical Microbiology and Infectious Diseases in Vienna examined the spread of Clostridium difficile bacteria, Gastroenterology and Endoscopy News reports.

Zacks analysts expect Allergan to post earnings of $3.32 per share for the first quarter of fiscal year 2017, The Cerbat Gem reports.

Here are the five most read gastroenterology/endoscopy stories from April 24 to April 30, 2017.

Michael Sagatelian, MD, is a gastroenterologist at Charleston, S.C.-based Palmetto Digestive Health Specialists.

Here are two gastroenterologists making headlines the week of April 24, 2017.

The American Gastroenterological Association Research Foundation awarded 52 researchers funding in its 2017 award year.

A study published in The Lancet Oncology examined surveillance colonoscopy's effect on colorectal cancer risk.

Motus GI Holdings announced that Flourtown, Pa.-based Hillmont GI was the first U.S. ambulatory endoscopy center to use its Pure-Vu system.

A study published in Gastroenterology examined the direct oral anticoagulants' gastrointestinal safety.

The FDA approved Stivarga for hepatocellular carcinoma patients. It's the first new FDA-approved liver cancer treatment in nearly a decade.